Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40771901	b-kml-qr	— (—)	168	1532	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Liquid cancers, helper endpoint

131

104.54

224.28

11.4

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

106

59.45

189.89

13.8

1.0

—

Other diseases of blood and blood-forming organs, wide

39.76

123.16

9.5

7.8

—

Myeloid leukaemia

+∞

102.91

14.7

0.0

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

102.46

15.2

0.0

—

Chronic myeloid leukaemia, including Hilmo

+∞

102.41

15.2

0.0

—

Chronic myeloid leukaemia

+∞

73.69

16.0

0.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9.27

61.93

9.2

9.4

—

Malignant neoplasm

11.38

51.68

12.7

1.0

—

Malignant neoplasm, wide definition for exclusion

10.97

49.02

12.9

1.0

—

Any event in cancer register

9.26

41.45

11.4

4.6

—

Neoplasms

14.97

35.78

12.8

1.0

—

L01XX Other antineoplastic agents

77.43

33.91

8.3

11.8

—

Other and unspecified diseases of blood and blood-forming organs

+∞

26.16

7.6

0.0

—

Other diseases of blood and blood-forming organs

40.49

25.83

7.0

11.4

—

Any reimbursement code in KELA

13.04

17.60

13.6

1.0

—

Bacterial infection, other or unspecified

4.59

15.47

11.4

8.8

—

Lymphoid leukaemia

28.81

15.19

13.2

13.3

—

Bacterial infection, other or unspecified

4.53

14.56

11.0

9.2

—

Leukaemia of unspecified cell type

+∞

12.57

12.9

0.0

—

Abnormal findings on examination of blood, without diagnosis

4.01

11.02

9.2

9.8

—

Other bacterial diseases

103

3.13

10.90

10.0

9.7

—

Heart failure, not strict

3.49

10.44

10.8

7.9

—

Gout, FINNGEN

4.61

10.41

11.8

9.0

—

Gout

4.70

10.23

11.8

7.7

—

Examination and observation for other reasons

4.63

10.02

8.7

7.9

—

Solid cancers, helper endpoint

4.35

9.45

7.8

1.0

—

Medical observation and evaluation for suspected diseases and conditions

4.24

8.96

9.8

7.9

—

All chronic kidney diseases

3.59

8.64

11.2

9.2

—

Pain, not elsewhere classified

4.75

8.57

11.5

7.8

—

Other bacterial diseases

105

2.78

8.48

9.6

9.2

—

Chronic myeloproliferative disease

+∞

8.35

5.4

0.0

—

Renal tubulo-interstitial diseases

110

2.78

7.91

9.7

8.7

—

Other abnormal findings of blood chemistry

18.43

7.60

4.5

13.8

—

All kidney diseases

112

2.62

7.34

9.4

9.0

—

Covid-19 confirmed case

3.73

7.33

7.0

9.8

—

Eosinophilia

+∞

7.30

1.0

0.0

—

Codes for special purposes

3.17

6.80

7.0

9.8

—

Provisional assignment of new diseases of uncertain etiology

3.17

6.80

7.0

9.8

—

Heart failure and antihypertensive medication

6.98

6.43

10.3

7.1

—

Fever of other and unknown origin

3.05

6.23

13.2

8.0

—

Renal failure

3.17

6.12

9.2

9.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

103

2.71

6.08

10.6

8.2

—

Heart failure,strict

3.26

6.00

10.1

8.5

—

COPD differential diagnosis

2.93

5.89

8.6

9.1

—

ILD differential diagnosis

2.93

5.89

8.6

9.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.47

5.86

11.3

7.9

—

Other heart diseases

3.42

5.77

12.8

8.2

—

2.49

5.59

9.5

8.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.49

5.59

9.5

8.2

—

Other pulmonary diagnosis

2.82

5.56

9.0

8.8

—

Excluding asthma or asthma-COPD overlap

2.82

5.56

8.6

8.8

—

Pneumonias (Asthma/COPD co-morbidities)

115

2.33

5.45

10.1

8.8

—

Persons encountering health services for examination and investigation

3.30

5.24

8.5

7.9

—

Anaemias

10.89

5.20

6.9

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

3.00

5.19

12.5

8.1

—

Asthma (mode)

2.83

5.17

6.3

9.1

—

All pneumoniae

118

2.27

5.12

10.1

8.9

—

Asthma, excluding more controls

2.95

5.09

6.6

9.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

5.19

5.06

12.9

6.5

—

Asthma (only as main-diagnosis), excluding more controls

2.98

4.95

6.3

9.0

—

Malignant neoplasm of skin

3.95

4.86

8.6

1.0

—

Certain infectious and parasitic diseases

2.38

4.86

12.8

7.2

—

Tramadol

2.46

4.78

11.1

8.8

—

Any death

2.57

4.76

6.5

9.7

—

Other and unspecified anaemias

2.90

4.76

10.3

8.3

—

Statin medication

2.71

4.73

10.6

8.7

—

Influenza and pneumonia

116

2.19

4.72

9.2

8.9

—

Caries of dentine

4.70

4.67

14.9

9.3

—

Other soft tissue disorders, not elsewhere classified

2.25

4.66

11.6

8.2

—

Other anaemias

2.85

4.63

10.3

8.3

—

Other medical care

2.79

4.60

6.5

8.4

—

Pneumonia, organism unspecified

108

2.27

4.59

10.8

9.4

—

Aplastic and other anaemias

2.77

4.59

9.9

8.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

118

2.20

4.58

10.6

9.0

—

COPD/asthma related infections

2.23

4.58

9.8

8.2

—

COPD/asthma/ILD related infections

2.23

4.58

9.7

8.2

—

Codeine

2.30

4.55

9.9

8.7

—

Any gastric operation

2.60

4.55

11.8

7.6

—

GASTRO-related operations

2.60

4.55

11.8

7.6

—

Asthma

2.67

4.52

6.5

9.1

—

Asthma (only as main-diagnosis)

2.73

4.49

6.1

9.1

—

All-cause Heart Failure

2.63

4.45

10.3

9.3

—

Diseases of oesophagus, stomach and duodenum

116

2.11

4.39

10.9

8.7

—

General symptoms and signs

2.18

4.38

11.2

8.3

—

Heart failure, strict

2.59

4.33

10.3

9.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3.80

4.31

10.4

1.0

—

Non-ischemic cardiomyopathy

3.45

4.29

10.7

6.5

—

Other heart diseases, wide

2.23

4.28

11.4

8.8

—

Acute bronchitis

2.87

4.27

12.1

9.0

—

Use of hypnotics and sedatives

117

2.06

4.19

11.7

8.6

—

Intestinal infectious diseases

128

2.13

4.18

11.9

8.2

—

Complications of medical and surgical care

122

2.26

4.16

10.0

8.8

—

Septicaemia

2.90

4.10

9.7

8.9

—

Oxycodone

2.91

4.08

9.4

7.6

—

Persons encountering health services for specific procedures and health care

117

2.05

4.00

10.2

8.9

—

Bronchitis

124

2.03

3.95

12.0

8.0

—

Pain in limb

2.21

3.93

12.8

8.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

110

2.33

3.93

10.0

8.5

—

Diseases of liver

2.88

3.89

7.8

9.0

—

Non-small cell lung cancer, including Hilmo

9.43

3.86

2.0

1.0

—

Other septicaemia

2.87

3.83

10.2

8.8

—

Nerve, nerve root and plexus disorders

122

2.01

3.82

9.9

9.2

—

Acute tubulo-interstitial nephritis

2.41

3.79

8.5

8.4

—

Biomechanical lesions, not elsewhere classified

12.03

3.76

9.8

13.6

—

Infections, IBD-co-morbidities

4.91

3.73

14.6

7.8

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.40

3.72

9.2

9.0

—

Dental caries

3.64

3.72

14.9

8.7

—

Hypothyroidism, drug reimbursement

9.88

3.69

7.4

1.2

—

Bacterial pneumonia, not elsewhere classified

2.73

3.66

10.9

9.4

—

Asthma, unspecified (mode), excluding more controls

2.89

3.66

7.9

9.1

—

Polyarthropathies

2.26

3.63

11.6

7.8

—

Bacterial pneumoniae

2.69

3.56

10.9

9.7

—

Other reaction to severe stress, and adjustment disorders

2.89

3.45

13.6

8.3

—

106

1.95

3.42

10.6

8.2

—

Opioids

2.05

3.34

10.9

8.8

—

Unspecified kidney failure

5.72

3.34

8.9

13.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.55

3.33

13.2

7.5

—

Injuries to the hip and thigh

2.45

3.33

9.9

8.8

—

Cardiovascular diseases

2.62

3.33

13.3

7.6

—

Benign neoplasms

2.01

3.31

10.6

8.1

—

Visual disturbances

2.41

3.29

10.1

9.1

—

Implicit viral Sepsis

3.93

3.28

15.2

8.2

—

Viral Sepsis

3.93

3.28

15.2

8.2

—

Non-Hodgkin lymphoma, all, including Hilmo

8.58

3.26

7.8

1.0

—

Codeine or tramadol medication

115

1.90

3.26

9.7

9.0

—

Malignant neoplasm of bladder, including Hilmo

8.52

3.25

5.3

1.0

—

Hypothyroidism, levothyroxine purchases

6.46

3.21

6.3

1.1

—

Hypothyroidism and >3 levothyroxin purchases

6.46

3.21

6.3

1.1

—

Hypothyroidism (congenital or acquired)

6.46

3.21

6.3

1.1

—

Chronic lower respiratory diseases

120

1.86

3.20

7.3

9.9

—

Insulin medication

2.22

3.19

9.6

9.9

—

Other diseases of anus and rectum

2.85

3.17

10.6

8.7

—

Malaise and fatigue

2.40

3.14

8.8

8.0

—

Malignant neoplasm of bronchus and lung

6.46

3.10

2.0

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

2.68

3.10

11.0

7.9

—

Acute renal failure

3.43

3.10

7.8

10.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

101

2.17

3.09

9.6

10.1

—

Chronic kidney disease

2.90

3.02

11.7

9.5

—

Diseases of arteries, arterioles and capillaries

2.11

3.00

11.8

8.2

—

Visual disturbances and blindness

2.30

2.99

10.1

8.8

—

Bacterial pneumonia (organism specified)

2.44

2.99

10.9

9.3

—

Malignant neoplasm of endocrine gland

10.01

2.98

9.6

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

10.01

2.98

9.6

1.0

—

Basal cell carcinoma, including avohilmo

3.45

2.95

8.4

1.0

—

Oedema, not elsewhere classified

2.85

2.94

8.4

7.4

—

Hypertensive diseases

2.08

2.94

8.7

9.7

—

Hypertension

2.08

2.93

8.7

9.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3.43

2.93

10.4

1.0

—

Diseases of the respiratory system

2.35

2.92

9.9

7.9

—

Depression medications

5.75

2.91

14.8

1.1

—

Other acute lower respiratory infections

2.27

2.89

11.5

10.1

—

Asthma, unspecified (mode)

2.51

2.88

7.9

9.2

—

Superficial injury of hip and thigh

4.09

2.87

10.1

10.2

—

Viral infections characterized by skin and mucous membrane lesions

133

1.93

2.83

10.2

8.8

—

Hypertensive diseases (excluding secondary)

2.49

2.81

10.4

7.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

4.45

2.79

6.0

11.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.92

2.77

8.2

11.7

—

Diarrhoea and gastroenteritis of presumed infectious origin

125

1.85

2.77

10.9

8.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

113

1.83

2.76

7.8

9.7

—

Atrial fibrillation and flutter

3.24

2.75

11.9

7.3

—

Ocular pain

8.34

2.75

20.4

13.5

—

Viral pneumonia

5.00

2.72

8.3

11.0

—

Cerebrovascular diseases (FINNGEN)

3.15

2.70

11.8

6.1

—

Insulin, intermediate and long-acting

2.15

2.70

9.9

—

Implicit viral Sepsis

2.59

2.69

14.2

8.4

—

Explicit Sepsis

2.30

2.69

9.7

8.1

—

Zoster [herpes zoster]

2.23

2.66

7.6

7.8

—

Poisoning by drugs, medicaments and biological substances

3.14

2.64

7.9

10.4

—

Hypertension, essential

2.01

2.63

7.7

9.7

—

Other diseases of intestines

113

1.81

2.62

9.9

9.1

—

Chronic gastritis

2.93

2.61

8.8

8.1

—

Fibrosis and cirrhosis of liver

4.67

2.59

3.4

11.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.67

2.59

14.6

12.2

—

Other and unspecified visual disturbances

4.67

2.59

7.0

12.5

—

Bacterial Sepsis

2.22

2.59

11.7

8.3

—

Malignant neoplasm of digestive organs

3.74

2.57

4.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

4.61

2.56

5.1

1.0

—

Other metabolic disorders

4.00

2.56

6.0

10.4

—

Anxiety disorders, excluding more controls

1.94

2.56

10.8

8.9

—

Complications of surgical and medical care, not elsewhere classified

129

1.80

2.55

9.9

9.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

107

2.05

2.55

9.9

8.7

—

Lesion of lateral popliteal nerve

7.16

2.55

13.0

9.6

—

L04AC Interleukin inhibitors

7.15

2.55

7.2

14.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.56

2.54

11.9

7.3

—

Persons encountering health services for specific procedures, not carried out

5.46

2.54

12.3

14.5

—

Fall on and from stairs and steps

2.73

2.54

8.4

8.5

—

Finngen Rheumatological endpoints

106

1.82

2.54

9.0

9.1

—

Basal cell carcinoma

3.17

2.53

9.1

1.0

—

Poisoning by medicine

3.23

2.51

8.6

10.3

—

Symptoms and signs involving the skin and subcutaneous tissue

126

1.94

2.49

9.4

9.1

—

Acute upper respiratory infections of multiple and unspecified sites

1.95

2.48

13.2

8.7

—

Other pleural conditions

4.38

2.47

12.6

9.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

4.51

2.46

2.0

1.0

—

Oral corticosteroids

121

1.76

2.45

8.2

9.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

4.48

2.45

2.0

1.0

—

Spondylosis

2.04

2.42

8.0

8.6

—

Myocardial infarction, without ST-elevation

2.25

2.41

8.9

9.0

—

Continuous positive airway pressure

3.45

2.41

18.0

7.5

—

Implicit bacterial Sepsis

2.25

2.41

12.0

8.1

—

All influenza

2.90

2.41

11.0

10.6

—

Agranulocytosis

6.25

2.37

10.6

11.4

—

Specific personality disorders

3.03

2.35

7.9

11.2

—

ILD medications: immunosuppressive drugs

103

1.98

2.32

8.2

10.0

—

Atrial fibrillation and flutter with reimbursement

3.18

2.32

7.6

6.1

—

Allergic asthma (mode), excluding more controls

3.56

2.31

3.3

8.7

—

Lower back pain or/and sciatica

132

1.73

2.30

9.1

—

Heart failure and bmi 25plus

2.58

2.29

6.5

9.7

—

Other diseases of intestine

3.48

2.26

6.0

8.0

—

3.89

2.25

5.9

11.4

—

Malignant neoplasm of prostate

5.13

2.22

11.2

1.0

—

Peripheral artery disease

2.18

2.22

14.5

7.6

—

Other specified and unspecified personality disorders

5.56

2.21

8.0

12.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.65

2.21

11.3

7.4

—

Personality disorders, excluding more controls

2.86

2.20

7.9

10.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.41

2.19

9.9

8.8

—

Inflammatory bowel disease treatment related agents

123

1.68

2.15

8.4

9.4

—

Transplanted organ and tissue status

3.69

2.15

13.3

11.1

—

Neurotic, stress-related and somatoform disorders

114

1.78

2.14

11.2

8.6

—

Any mental disorder

106

1.70

2.12

11.1

8.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.77

2.12

7.5

8.1

—

Other specific joint derangements/joint disorders

1.89

2.09

11.7

7.9

—

Early onset COPD, excluding more controls

3.20

2.09

10.3

9.6

—

malignant neoplasm of male genital organs

4.57

2.07

11.2

1.0

—

Conductive hearing loss, unspecified

5.01

2.07

6.2

15.8

—

Implicit bacterial Sepsis

2.10

2.06

12.0

8.4

—

Asthma-related pneumonia

2.25

2.06

4.9

9.5

—

Asthma, hospital admissions 3, pneumonia

2.25

2.06

4.9

9.5

—

Asthma-related pneumonia or sepsis

2.25

2.06

4.9

9.5

—

Anxiety disorders

115

1.76

2.06

11.2

8.6

—

Erysipelas

2.09

2.05

7.0

9.4

—

Purpura and other haemorrhagic conditions

3.50

2.05

8.4

9.8

—

Diseases of the eye and adnexa

1.86

2.04

12.3

8.4

—

Allergic asthma (mode)

3.13

2.04

3.3

9.4

—

Cardiac arrhythmias

2.00

2.04

9.6

8.7

—

Parasetamol

1.86

2.03

10.9

9.9

—

Acute pharyngitis

3.47

2.03

5.0

11.7

—

Malignant neoplasm of prostate, including Hilmo

4.46

2.02

11.2

1.0

—

Diabetes, varying definitions

114

1.70

2.02

8.7

9.4

—

Intestinal infectious diseases

124

1.66

2.02

11.9

8.4

—

Diabetes mellitus

114

1.69

2.00

8.7

9.4

—

Coagulation defects, purpura and other haemorrhagic conditions

2.81

2.00

6.8

8.9

—

Coxarthrosis, primary, with hip surgery

2.01

1.99

6.9

8.6

—

Chronic periodontitis, including avohilmo

127

1.69

1.98

9.0

9.3

—

Spondylopathies

1.75

1.98

9.2

9.3

—

Soft tissue disorders

100

1.70

1.97

11.7

8.3

—

Viral infections characterized by skin and mucous membrane lesions

2.14

1.97

11.9

9.3

—

ILD medications

114

1.66

1.97

8.0

9.6

—

Periodontitis

127

1.68

1.97

9.0

9.3

—

Heart failure and coronary heart disease

2.14

1.96

7.9

8.4

—

Other inflammation of eyelid

3.34

1.96

5.6

10.0

—

Arthropathies

1.75

1.96

11.7

7.9

—

Implicit Sepsis

105

1.80

1.94

11.0

9.0

—

Pneumonitis due to solids and liquids

4.55

1.94

6.4

8.9

—

Suicide or other Intentional self-harm

2.57

1.94

7.5

8.4

—

Diabetes medication

117

1.67

1.93

8.1

9.5

—

Other viral diseases

2.44

1.91

10.5

10.8

—

Complications of procedures, not elsewhere classified

123

1.75

1.90

10.2

9.0

—

Coxarthrosis, primary

1.87

1.89

6.9

8.8

—

Autoimmune diseases related-to ILD

134

1.72

1.88

7.6

9.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.86

1.88

10.0

7.9

—

Nutritional anaemias

2.00

1.88

8.4

8.5

—

Other disorders of the musculoskeletal system and connective tissue

3.18

1.88

9.4

11.1

—

Gingivitis and periodontal diseases

1.68

1.87

11.1

9.0

—

Endocrine, nutritional and metabolic diseases

1.78

1.87

8.6

9.8

—

Cystitis

1.73

1.87

10.1

7.7

—

Spinal stenosis

1.90

1.85

9.5

8.4

—

Biguanides

113

1.67

1.84

6.9

9.4

—

Pain in joint

1.95

1.83

11.5

8.6

—

Other disorders of nervous system

4.17

1.82

17.4

10.9

—

Chronic periodontitis, complicated

100

1.88

1.80

9.0

8.8

—

Benign neoplasm of other and unspecified endocrine glands

3.05

1.80

8.3

10.5

—

Benign neoplasm of ovary

3.05

1.80

6.9

9.5

—

Iron deficiency anaemia

2.05

1.79

8.0

9.1

—

Pleural effusion

2.76

1.79

8.9

9.8

—

Hyperplasia of prostate

2.13

1.75

8.3

11.0

—

Bell's palsy

3.34

1.74

11.7

9.3

—

Pain in throat and chest

1.71

1.73

12.4

10.2

—

Diseases of oral cavity, salivary glands and jaws

1.91

1.72

12.2

7.9

—

Acute upper respiratory infections

122

1.62

1.69

10.7

8.1

—

Asthma, hospital admission 2, infections

1.88

1.69

6.2

10.4

—

Asthma-related infections

1.88

1.69

6.2

10.4

—

Disorders of vitreous body

1.87

1.68

7.3

8.9

—

Coxarthrosis

1.87

1.66

7.5

7.2

—

Unspecified privation

3.16

1.66

6.7

11.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.16

1.66

3.2

10.3

—

Persistent mood disorders

2.80

1.65

5.9

9.8

—

Zoster [herpes zoster]

2.80

1.65

10.4

7.1

—

Type 2 diabetes, definitions combined, including avohilmo

107

1.63

1.64

7.3

9.4

—

COPD

1.95

1.64

8.9

9.8

—

Personality disorders

2.44

1.64

7.9

11.4

—

Diabetes, insulin treatment (Kela reimbursement)

121

1.60

1.62

9.7

9.5

—

Cough

1.97

1.62

6.2

9.7

—

Benign neoplasm: Adrenal gland

3.58

1.61

11.0

13.7

—

Abscess of anal and rectal regions

3.57

1.61

10.8

9.4

—

Overexertion and strenuous or repetitive movements

3.57

1.61

14.6

14.0

—

Heartburn

3.57

1.61

10.4

8.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

121

1.61

11.0

8.7

—

Hypertensive heart and/or renal disease

2.41

1.61

14.1

9.2

—

Disorders of vitreous body and globe

1.84

1.60

7.3

8.8

—

Exposure to other specified factors

124

1.70

1.59

12.7

9.2

—

Insulin, fast-acting

2.06

1.59

9.7

9.9

—

Otitis media, unspecified

3.54

1.58

6.2

12.6

—

Chronic sinusitis

1.95

1.58

8.9

9.7

—

Other embolism and thrombosis

3.00

1.58

13.8

8.6

—

Generalized anxiety disorder

3.00

1.58

10.3

11.2

—

Hernia of abdominal wall, postoperative

3.00

1.58

2.8

6.3

—

Fracture of femur

2.33

1.58

7.6

9.4

—

Other viral diseases

2.13

1.58

9.7

10.3

—

Dysplasia of cervi uteri

0.00

1.56

0.0

7.5

—

Gastro-oesophageal reflux disease

104

1.74

1.56

12.5

8.4

—

Disorders of adult personality and behaviour

2.27

1.55

7.9

11.7

—

Certain infectious and parasitic diseases

1.75

1.54

10.2

7.5

—

Other diseases of pleura

1.90

1.54

8.8

9.1

—

Diseases of male genital organs

1.89

1.53

8.7

11.9

—

Coxarthrosis [arthrosis of hip](FG)

1.81

1.53

7.5

7.9

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

1.52

0.0

8.4

—

Fall on same level involving ice and snow

100

1.80

1.52

11.5

9.6

—

Abnormal weight loss

3.34

1.52

1.0

11.3

—

First line medication for Crohn's disease

114

1.56

1.52

8.8

9.4

—

Cerebral palsy and other paralytic syndromes

3.34

1.52

14.6

13.8

—

Benzodiazepine use

136

1.57

1.52

7.7

9.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

112

1.64

1.51

11.4

9.2

—

Lung cancer and mesothelioma

2.61

1.49

2.0

8.1

—

Gout, unspecified

2.43

1.47

9.8

9.6

—

Diseases of middle ear and mastoid

1.80

1.47

6.4

10.5

—

Type 2 diabetes, strict (exclude DM1)

107

1.59

1.46

7.2

9.1

—

Acute sinusitis

1.85

1.46

9.2

8.7

—

Asthma, hospital admissions , main diagnosis only

136

1.62

1.46

6.1

9.6

—

Other and unspecified effects of external causes

2.22

1.46

13.3

9.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.22

1.46

7.5

9.4

—

Weight loss

3.13

1.44

1.0

12.1

—

Flat foot [pes planus] (acquired)

3.13

1.44

14.4

8.3

—

L04AD Calcineurin inhibitors

3.13

1.44

12.2

12.6

—

Symptoms and signs concerning food and fluid intake

3.12

1.43

1.0

8.1

—

Rheumatism, unspecified

2.73

1.43

2.0

8.5

—

Asthma (diagnoses ohter than nonallergic)

135

1.60

1.42

6.2

9.5

—

Asthma, including avohilmo

130

1.51

1.42

6.0

10.1

—

Suppurative and unspecified otitis media

2.05

1.42

6.7

11.4

—

Type 2 diabetes, definitions combined

108

1.58

1.42

7.2

9.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

111

1.57

1.42

8.7

9.4

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.37

1.42

12.4

8.9

—

Non-rheumatic valve diseases

1.94

1.40

13.1

7.9

—

Dizziness and giddiness

111

1.64

1.39

7.6

9.5

—

Malignant neoplasm of breast, HER2-negative

2.26

1.38

12.1

1.0

—

Malignant neoplasm of breast

2.26

1.37

12.1

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.20

1.36

11.1

6.9

—

Subjective visual disturbances

2.20

1.36

9.4

8.4

—

Budesonide

2.61

1.36

11.8

10.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.24

1.36

12.1

1.0

—

Malignant neoplasm of breast, including Hilmo

2.24

1.36

12.1

1.0

—

COPD (mode)

2.21

1.36

6.9

9.0

—

Suggestive for eosinophilic asthma

2.94

1.36

1.0

12.0

—

Hypokalaemia

2.94

1.36

11.6

10.4

—

Metabolic disorders

114

1.55

1.35

10.0

9.7

—

All dysplastic lesions of the cervix uteri

0.00

1.34

0.0

8.7

—

Valvular heart disease excluding rheumatic fever

1.91

1.34

13.1

7.9

—

Nontoxic goitre/thyroid nodule

2.13

1.33

9.0

8.9

—

Other chronic obstructive pulmonary disease, including avohilmo

1.73

1.32

8.1

9.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

114

1.57

1.31

11.0

9.1

—

Type 2 diabetes

110

1.54

1.31

7.2

9.4

—

Pain (limb, back, neck, head abdominally)

1.67

1.30

9.0

8.5

—

Other disorders of eye and adnexa

2.50

1.30

17.2

10.8

—

Gastric ulcer

2.50

1.30

12.3

8.0

—

Disorders of tooth development and eruption

2.89

1.30

14.8

8.3

—

Other specified/unspecified arthritis

2.09

1.30

7.3

6.9

—

Other (not insulin) diabetes medications

112

1.54

1.30

6.7

9.4

—

Anxiety (asthma-related co-morbidities)

1.75

1.29

12.6

9.4

—

Insulin, fast-acting or short human

1.88

1.28

9.7

10.0

—

Nausea and vomiting

2.05

1.27

9.0

6.6

—

Gout, strict definition

2.29

1.26

10.1

8.9

—

Abdominal and pelvic pain

103

1.51

1.26

13.5

8.4

—

Other condition

2.40

1.24

14.7

10.2

—

Adjustment and management of implanted device

2.40

1.24

12.7

8.5

—

Lung diseases due to external agents

2.40

1.24

5.5

11.1

—

Hard cardiovascular diseases

1.57

1.23

11.0

7.9

—

Gout, idiopatic and unspecified

2.00

1.23

9.8

9.7

—

Headache

1.72

1.23

10.1

7.7

—

Obesity, other/unspecified

1.96

1.22

5.7

9.4

—

Other disorders of kidney and ureter

2.63

1.21

6.4

11.7

—

Autoimmune diseases excluding thyroid diseases

118

1.48

1.21

9.9

9.2

—

Gastroduodenal ulcer

2.16

1.21

9.5

8.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.84

1.20

10.1

9.3

—

Other neurological diseases

109

1.59

1.19

12.8

8.2

—

Abnormal findings on diagnostic imaging of lung

1.75

1.19

10.3

8.6

—

Coronary artery bypass grafting

2.07

1.19

10.1

8.1

—

Nonorganic sleeping disorders, excluding more controls

2.31

1.18

9.8

8.0

—

Mood disorders, excluding more controls

101

1.54

1.18

10.0

8.8

—

Phlebitis and thrombophlebitis (not including DVT)

2.11

1.18

11.6

6.9

—

Myocardial infarction

1.73

1.16

10.8

8.3

—

Unstable angina pectoris

1.89

1.16

10.8

8.2

—

Low back pain

106

1.56

1.15

9.6

9.2

—

Burns and corrosions

2.50

1.15

16.8

10.5

—

Fissure and fistula of anal and rectal regions

2.05

1.15

14.6

8.5

—

Substance abuse, excluding more controls

1.70

1.15

9.0

9.5

—

Thyrotoxicosis, other and/or unspecified

0.00

1.15

0.0

8.8

—

Implicit Sepsis

114

1.54

1.15

11.4

9.2

—

Stroke, excluding SAH

1.63

1.14

10.4

8.5

—

Bleeding

111

1.54

1.14

9.8

9.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.76

1.13

11.4

8.7

—

Other diseases of liver

2.33

1.12

7.0

8.7

—

Used for control exclusion in common control thyroid runs

107

1.46

1.11

10.0

9.3

—

Malignant neoplasm of breast, HER-positive

2.27

1.10

11.9

1.0

—

Other respiratory diseases principally affecting the interstitium

2.26

1.10

8.7

9.9

—

Malignant neoplasm of breast, ER-positive, including Hilmo

2.25

1.09

11.9

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

106

1.47

1.09

11.3

8.9

—

Other chronic obstructive pulmonary disease

1.75

1.09

8.8

9.8

—

Insulin, fast-acting (human)

2.38

1.09

16.2

11.2

—

Candidiasis

2.38

1.09

17.6

10.4

—

All influenza (not pneumonia)

2.38

1.09

10.2

12.8

—

Diagnoses used for exclusion with ILD

1.95

1.08

4.4

9.6

—

Persons encountering health services in circumstances related to reproduction

0.49

1.08

13.8

9.8

—

Other and unspecified iron deficiency

1.86

1.07

10.5

8.4

—

Disorders of lipoprotein metabolism and other lipidaemias

1.52

1.06

9.2

9.4

—

Pure hypercholesterolaemia

1.54

1.06

10.8

9.3

—

Other and unspecified polyneuropathies, also in other diseases

2.12

1.05

13.7

8.6

—

Adverse effects, not elsewhere classified

2.12

1.05

13.1

9.5

—

Acute pancreatitis (for exclusion)

2.12

1.05

14.4

8.7

—

Other or unspecified ileus, impaction or obstruction

2.12

1.05

13.1

8.2

—

Disorders of other endocrine glands

1.75

1.05

8.3

9.2

—

Dermatophytosis

2.27

1.03

15.0

10.3

—

Benign leiomyoma with endometriosis

2.27

1.03

11.0

10.0

—

Mycoses

1.96

1.03

15.4

8.7

—

Excessive attrition of teeth

1.63

1.03

9.8

10.1

—

Benign neoplasm: Rectum, anus and anal canal

2.06

1.02

10.9

8.5

—

Diseases of pulp and periapical tissues and dental caries

1.58

1.00

9.9

8.8

—

Acute pancreatitis

2.00

1.00

14.4

8.9

—

Superficial injury of head

2.00

1.00

10.6

7.7

—

Erysipelas

1.56

0.99

7.3

9.1

—

Abnormal serum enzyme levels

1.87

0.99

8.2

10.7

—

Combinations of oral blood glucose lowering drugs

1.84

0.98

7.0

10.1

—

Other arthritis (FG)

1.84

0.98

7.3

7.7

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.98

0.0

7.3

—

Chronic pancreatitis

2.17

0.98

9.0

10.3

—

Mucosal proctocolitis

2.17

0.98

7.0

10.1

—

Other bacterial intestinal infections

2.17

0.98

15.4

7.3

—

Venous thromboembolism

1.61

0.98

11.6

8.6

—

Other disorders of urethra and urinary system

1.54

0.97

10.9

7.8

—

Myocardial infarction, strict

1.69

0.96

9.8

8.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

124

1.40

0.96

8.5

9.5

—

Calcific aortic valvular stenosis

1.78

0.95

15.4

7.7

—

Calcific aortic valvular stenosis, operated

1.78

0.95

15.4

7.7

—

Operations 2 for CAVS

1.78

0.95

15.4

7.7

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.78

0.95

15.4

7.7

—

Calcific aortic valvular stenosis, including rheumatic fever

1.78

0.95

15.4

7.7

—

Other and unspecified disorders of vitreous body

1.69

0.94

4.7

8.6

—

Ischaemic heart disease, wide definition

1.50

0.94

12.5

8.3

—

Exclusions for E4_PCOS_BROAD

2.22

0.93

3.7

9.9

—

Other dorsopathies, not elsewhere classified

107

1.42

0.93

9.0

9.3

—

Paroxysmal tachycardia

2.18

0.92

11.3

7.0

—

Other joint disorders

1.47

0.92

12.3

7.8

—

STROKE

1.60

0.91

11.2

7.3

—

Hyperparathyroidism

2.12

0.90

10.8

8.6

—

Other and unspecified dermatitis

1.60

0.90

8.9

9.3

—

Symptoms and signs involving the digestive system and abdomen

103

1.41

0.90

13.6

8.4

—

L04AX Other immunosuppressants

102

1.57

0.90

5.6

10.0

—

Depression

124

1.42

0.89

10.0

9.1

—

Stroke, including SAH

1.51

0.88

10.4

8.5

—

Autoimmune diseases

118

1.38

0.88

10.3

9.2

—

Coronary atherosclerosis

1.52

0.88

12.2

7.9

—

Strabismus

1.90

0.88

8.5

8.9

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.79

0.87

13.6

9.3

—

Intestinal stricture

1.79

0.87

11.9

9.2

—

All anxiety disorders

1.54

0.87

12.6

9.0

—

Benign neoplasm: Rectum

2.00

0.87

10.2

9.5

—

Dental operations

1.51

0.86

11.5

9.0

—

Presence of cardiac and vascular implants and grafts

1.63

0.86

11.0

8.9

—

Autoimmune diseases excluding thyroid diseases, strict definition

114

1.39

0.86

10.2

9.4

—

Dorsalgia

107

1.40

0.86

9.8

9.3

—

Early onset COPD

1.82

0.85

10.3

9.6

—

Open wound of head

1.57

0.85

12.7

9.3

—

Status post-ami

1.79

0.84

17.3

8.2

—

Salpingitis and oophoritis

1.94

0.84

4.0

8.9

—

Other skin changes

1.94

0.84

5.7

8.8

—

DVT of lower extremities

1.94

0.84

18.2

7.6

—

Covid-19 suspected case

1.94

0.84

5.2

10.6

—

Periapical abscess

1.63

0.84

8.1

10.2

—

Benign neoplasm of colon, rectum, anus and anal canal

104

1.50

0.84

11.8

8.6

—

Dysphagia

1.78

0.84

6.3

6.9

—

Conductive and sensorineural hearing loss

108

1.44

0.84

7.6

8.7

—

Ischaemic Stroke, excluding all haemorrhages

1.52

0.82

11.0

8.3

—

Effects of foreign body entering through natural orifice

1.74

0.82

7.1

10.6

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

113

0.60

0.82

9.5

9.6

—

Triptan medication for migraine, single purchase ok

113

0.60

0.82

9.5

9.6

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

127

1.40

0.82

8.9

9.6

—

Benign neoplasm of other and ill-defined parts of digestive system

1.88

0.81

13.8

8.8

—

Schizophrenia or delusion, excluding more controls

1.72

0.81

3.5

10.0

—

Second line medication for Crohn's disease

105

1.52

0.81

5.6

10.0

—

Sciatica+with lumbago

1.55

0.81

9.3

—

Other functional intestinal disorders

1.61

0.80

8.2

8.8

—

Disorders of parathyroid gland

1.85

0.80

10.8

8.4

—

Psychiatric diseases

1.39

0.80

9.4

8.8

—

Abnormal spermatozoa

0.00

0.79

0.0

8.4

—

Dilated cardiomyopathy

0.00

0.79

0.0

9.5

—

Benign mammary dysplasia

0.00

0.79

0.0

9.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.82

0.79

12.5

7.5

—

Other bacterial intestinal infections

1.82

0.79

13.5

6.5

—

Fracture of lumbar spine and pelvis

1.82

0.79

9.3

8.9

—

Sleep apnoea

138

0.66

0.79

7.8

9.3

—

Postmenopausal bleeding

1.78

0.78

10.6

5.6

—

Ulcerative colitis

1.67

0.78

7.4

9.1

—

Colonic or urogenital fistula

1.67

0.78

14.6

8.6

—

Diseases of the ear and mastoid process

115

1.35

0.78

8.0

9.4

—

Dementia in Alzheimer disease

0.00

0.78

0.0

10.1

—

Viral and other specified intestinal infections

1.81

0.78

15.0

10.1

—

Other disorders of skin and subcutaneous tissue

116

1.46

0.78

8.8

9.1

—

Noninfective enteritis and colitis

1.58

0.77

8.4

9.9

—

Diverticular disease of intestine

1.45

0.77

11.5

8.9

—

Other disorders of ear

118

1.39

0.77

8.6

9.2

—

Mood [affective] disorders

128

1.37

0.76

9.7

9.2

—

Car occupant injured in other and unspecified transport accidents

1.77

0.76

13.2

10.1

—

Substance use, excluding alcohol

1.77

0.76

13.7

10.6

—

Nonorganic sleeping disorders

1.77

0.76

9.8

10.3

—

Chondropathies

0.00

0.76

0.0

11.5

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.76

0.0

9.8

—

Mood disorders

128

1.36

0.76

9.7

9.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.71

0.75

9.0

10.0

—

Hypertensive Heart Disease

1.89

0.74

10.1

9.4

—

Migraine with aura and triptan purchases

2.08

0.74

9.6

12.6

—

Ulcer of lower limb, not elsewhere classified

2.08

0.74

10.0

9.7

—

Persons encountering health services in other circumstances, wide

124

1.33

0.73

9.3

9.5

—

DVT of lower extremities and pulmonary embolism

1.59

0.73

12.6

8.6

—

Psoriasis

1.64

0.73

6.9

9.0

—

Diseases of salivary glands

1.64

0.73

6.9

9.2

—

Haemorrhoids and perianal venous thrombosis

1.63

0.73

11.8

8.9

—

Intracranial trauma

1.48

0.72

13.0

8.4

—

Chronic laryngitis and laryngotracheitis

2.00

0.72

7.6

7.7

—

Psoriasis vulgaris

1.80

0.72

5.9

8.8

—

Polyneuropathies and other disorders of the peripheral nervous system

1.80

0.72

13.7

8.1

—

COPD, early/later onset

1.53

0.72

8.8

9.4

—

Glucosamine medication

1.53

0.71

9.4

8.2

—

Haemorrhage from respiratory passages

1.67

0.71

6.0

9.8

—

Substance abuse

102

1.47

0.71

9.0

11.0

—

L04AA Selective immunosuppressants

1.75

0.71

11.6

8.0

—

Migraine with aura

1.75

0.71

9.7

8.2

—

Dislocation, sprain and strain of joints and ligaments of knee

100

1.47

0.71

11.8

10.1

—

Neurological diseases, wide definition

1.76

0.71

15.7

7.8

—

Inflammatory bowel disease

1.58

0.71

8.4

10.1

—

Artificial joint operation, meniscal resection

127

0.66

0.71

10.7

8.9

—

Fall on same level

128

1.32

0.70

9.7

9.3

—

Allergic conjunctivitis

1.49

0.70

9.2

8.3

—

Other interstitial pulmonary diseases

1.92

0.70

11.8

10.0

—

Somatoform disorder

1.92

0.70

9.6

8.6

—

Senile cataract

1.44

0.70

11.8

8.5

—

Disturbances of skin sensation

1.71

0.69

11.1

9.7

—

1.57

0.69

6.6

10.6

—

Irregular menses

1.58

0.69

8.6

8.3

—

Other antidepressants

107

1.34

0.69

12.1

8.5

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.60

0.68

9.0

8.4

—

ILD, hospital admissions

1.85

0.68

11.8

9.6

—

Interstitial lung disease

1.85

0.68

11.8

9.6

—

Interstitial lung disease endpoints

1.85

0.68

11.8

9.6

—

Bacterial intestinal infections, IBD co-morbidities

1.85

0.68

15.4

8.5

—

Abnormalities of breathing

1.38

0.68

6.9

10.0

—

Paralytic ileus and intestinal obstruction

1.67

0.68

13.1

8.6

—

Urolithiasis

1.53

0.68

12.0

9.6

—

Obesity

106

1.46

0.68

5.8

9.7

—

Antihypertensive medication - note that there are other indications

1.57

0.68

15.2

9.3

—

Type 2 diabetes, wide definition

1.41

0.67

8.1

9.0

—

Obesity and other hyperalimentation

106

1.45

0.67

5.8

9.7

—

Recurrent or chronic depression

1.61

0.67

11.6

9.4

—

Other external causes of accidental injury

1.37

0.66

10.3

8.1

—

Biological medication for rheuma

1.79

0.66

10.4

11.1

—

Ischemic heart diseases

1.38

0.66

12.3

7.8

—

Falls/tendency to fall

110

1.32

0.65

11.4

8.6

—

Dermatitis and eczema

137

1.31

0.65

8.9

9.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.61

0.65

4.4

8.8

—

Exposure to unspecified factor

141

1.33

0.65

10.8

8.8

—

Deviated nasal septum

1.61

0.64

12.1

9.1

—

Mental and behavioural disorders due to psychoactive substance use

103

1.44

0.64

9.0

10.9

—

COPD, hospital admission 2, with asthma infections

1.62

0.64

8.2

9.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.72

0.64

4.4

9.5

—

Other and unspecified nonorganic psychotic disorders

1.72

0.64

3.4

12.6

—

COPD related to multimorbidity

1.54

0.63

9.6

9.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

115

1.40

0.63

10.3

8.4

—

Sensorineural hearing loss

104

1.37

0.63

7.9

8.6

—

Excessive earwax

101

1.45

0.63

9.3

9.4

—

Arthrosis

1.39

0.62

9.7

7.5

—

Coxibs

1.62

0.62

7.4

10.5

—

Other and unspecified tonsillitis

1.64

0.62

11.5

10.7

—

Exclusions for E4_PCOS_CONSORTIUM

1.42

0.61

10.9

7.9

—

Injury, poisoning and certain other consequences of external causes

1.49

0.60

11.9

8.5

—

Carpal tunnel syndrome

1.44

0.60

7.1

8.4

—

Pleural plaque

0.00

0.60

0.0

8.3

—

Achilles tendinitis

0.00

0.60

0.0

9.5

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.59

0.0

8.9

—

Type of accident

1.54

0.59

13.9

8.9

—

Candidiasis

1.54

0.59

13.3

9.1

—

Depression or dysthymia

1.40

0.59

12.5

8.9

—

Abnormal involuntary movements

0.00

0.58

0.0

9.7

—

HSIL lesion of the cervix uteri

0.00

0.58

0.0

11.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

114

0.61

0.57

8.0

9.0

—

Other gastritis (incl. Duodenitis)

1.71

0.57

9.5

7.7

—

5-aminosalicylic acid

1.71

0.57

9.3

9.7

—

Injuries to the head

139

1.28

0.57

11.6

8.6

—

Dermatitis

114

1.40

0.57

9.2

9.0

—

Dementia, including avohilmo

0.55

0.57

6.8

8.5

—

Dental caries, including avohilmo

1.36

0.57

9.3

9.0

—

Spondylolisthesis/Spondylolysis

1.67

0.56

10.3

8.4

—

Syncope and collapse

1.52

0.56

11.6

8.2

—

Other diseases of lip and oral mucosa

1.51

0.56

7.8

9.4

—

Schizophrenia or delusion

1.45

0.56

3.5

11.3

—

Schizophrenia, schizotypal and delusional disorders

1.45

0.56

3.5

11.3

—

Other anxiety disorders

1.51

0.56

13.6

8.3

—

Myalgia

1.62

0.55

10.2

7.3

—

Other arrhythmias

1.41

0.55

12.6

8.3

—

Asthma/COPD (KELA code 203)

120

1.31

0.55

6.4

9.9

—

Abnormalities of heart beat

1.50

0.54

6.7

9.4

—

Menorrhagia

1.47

0.54

8.1

6.7

—

Diseases of external ear

1.48

0.53

10.8

8.8

—

Kela-code for severe mental illness

1.48

0.53

7.0

11.3

—

Ovarian cyst

1.44

0.53

8.6

7.0

—

Diaphragmatic hernia

1.45

0.53

11.6

8.9

—

Disorders of refraction and accommodation

1.53

0.52

15.3

9.5

—

Internal derangement of knee

1.44

0.52

8.4

8.2

—

Systemic connective tissue disorders

1.43

0.52

2.6

8.7

—

Other nutritional deficiencies

110

1.37

0.52

5.8

9.5

—

Transport accidents

1.45

0.52

13.3

8.8

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.40

0.52

9.8

8.3

—

Major coronary heart disease event

1.32

0.51

10.6

8.3

—

Injuries to the neck

1.50

0.51

14.0

9.5

—

COPD, hospital admissions

1.43

0.51

9.4

9.2

—

COPD, hospital admissions 1, only main diagnosis

1.40

0.51

12.4

9.3

—

Disorders of eyelid, lacrimal system and orbit

129

1.29

0.50

9.5

9.0

—

Functional dyspepsia

1.56

0.48

12.9

8.1

—

Polyuria

1.52

0.48

10.3

9.4

—

Shoulder lesions

1.32

0.48

7.5

7.9

—

Speech therapy

1.49

0.47

12.9

8.4

—

Melanocytic naevi

1.46

0.46

4.3

9.6

—

Chronic apical periodontitis

128

1.25

0.46

11.6

8.4

—

Sleep apnoea, including avohilmo

138

0.76

0.46

8.5

9.5

—

Disorders of gallbladder, biliary tract and pancreas

125

1.26

0.46

10.4

8.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

127

1.26

0.46

11.5

8.8

—

Gonarthrosis, primary, with knee surgery

0.66

0.46

5.9

8.9

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.43

0.46

6.6

10.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.43

0.46

6.6

10.0

—

Injuries to the knee and lower leg

135

1.23

0.45

9.1

—

Selective serotonin reuptake inhibitors

108

1.26

0.45

11.2

8.6

—

Emergency coronary revascularization (for ACS)

1.29

0.45

11.0

8.2

—

Soft tissue disorders related to use, overuse and pressure

1.40

0.45

16.6

7.9

—

Fenamates

1.70

0.44

14.0

8.1

—

Unspecified mental disorder

1.45

0.44

7.5

11.3

—

Acute alcohol intoxication

1.37

0.44

7.3

9.9

—

External causes of morbidity and mortality

1.33

0.44

10.9

8.0

—

Rotator cuff syndrome

1.34

0.43

8.6

7.9

—

Polycystic ovarian syndrome, consortium definition

1.33

0.43

8.3

7.6

—

Later onset COPD, excluding more controls

1.61

0.43

5.2

7.8

—

Benign lipomatous neoplasm

1.43

0.42

8.3

9.0

—

Other diseases of the digestive system

1.43

0.42

9.0

8.7

—

GI-bleeding

1.43

0.42

9.0

8.7

—

Glomerular diseases

1.56

0.42

15.4

9.3

—

Viral warts

1.56

0.42

11.8

8.8

—

Endometriosis ASRM stages 3,4

1.56

0.42

9.4

9.7

—

Reimbursement for rheumatic diseases

104

1.34

0.42

5.3

9.6

—

Diseases of the digestive system

1.40

0.42

11.9

8.7

—

Cerebrovascular diseases

104

1.28

0.41

12.1

8.4

—

Symptoms and signs involving the urinary system

113

1.28

0.41

9.3

9.2

—

Angina pectoris

1.33

0.41

12.3

7.6

—

Sequelae with surgical and medical care as external cause

1.52

0.41

10.2

8.9

—

Otosclerosis

0.00

0.41

0.0

14.1

—

Nonischemic cardiomyopathy

0.00

0.41

0.0

8.5

—

Carcinoma in situ of skin

0.00

0.41

0.0

9.8

—

Other appendicitis

0.00

0.41

0.0

13.4

—

Bitten or struck by other mammals

0.00

0.41

0.0

13.7

—

Other peripheral vertigo

0.00

0.41

0.0

12.1

—

LSIL lesion of the cervix uteri

0.00

0.41

0.0

9.6

—

Normotensive glaucoma

0.00

0.40

0.0

11.5

—

Alcohol use disorder, ICD-based

1.39

0.40

6.7

10.6

—

Disorders of lens

1.29

0.40

11.1

8.3

—

Sleep disorders

127

1.25

0.40

7.6

9.3

—

Caries of dentine, including avohilmo

1.28

0.40

10.3

9.0

—

Type 1 diabetes, wide definition, subgroup 1

1.47

0.40

16.2

11.1

—

Other strabismus

1.47

0.40

7.8

9.4

—

Percutaneous Coronary Intervention

1.28

0.40

11.3

7.9

—

Non-selective monoamine reuptake inhibitors

1.42

0.40

13.2

7.2

—

Other noninflammatory disorders of vulva and perineum

0.00

0.40

0.0

10.1

—

Infective dermatitis

0.00

0.40

0.0

10.6

—

Preterm labour and delivery

1.43

0.39

9.6

9.9

—

Other/unspecified rheumatoid arthritis

0.00

0.39

0.0

10.4

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.39

0.0

10.5

—

Concussion

1.34

0.39

13.0

8.4

—

Cholecystectomy

128

0.74

0.38

9.7

8.8

—

Accidents

1.25

0.38

8.6

8.1

—

Disorders of conjunctiva

128

1.25

0.38

11.8

8.7

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.39

0.38

7.6

8.8

—

Herpesviral [herpes simplex] infections

1.39

0.38

16.8

9.8

—

Gastrointestinal diseases

1.36

0.38

13.5

8.5

—

Cardiodefibrillation

1.32

0.37

11.1

8.9

—

Coronary revascularization (ANGIO or CABG)

1.26

0.37

10.6

7.8

—

Nasal polyp

1.35

0.37

1.0

9.0

—

severe traumatic brain injury, does not include concussion

1.35

0.37

10.6

9.4

—

Type 1 diabetes, wide definition

1.35

0.37

16.2

10.8

—

Glaucoma suspect

1.29

0.36

9.0

8.5

—

Other/unspecified dorsalgia

1.27

0.36

6.2

8.8

—

Chronic diseases of tonsils and adenoids

0.75

0.36

9.6

9.2

—

Major coronary heart disease event excluding revascularizations

1.30

0.36

9.7

8.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.63

0.35

4.8

8.6

—

Aortic aneurysm

1.44

0.35

9.5

8.4

—

Use of pramipexole

1.43

0.35

9.0

7.8

—

Irritable bowel syndrome

1.43

0.35

11.8

9.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

0.63

0.35

6.8

8.7

—

Conduction disorders

1.39

0.35

12.2

7.2

—

Other noninfective gastroenteritis and colitis

1.39

0.35

5.8

8.6

—

Haemorrhage in early pregnancy

1.39

0.35

11.5

8.0

—

Artrosis, including avohilmo

103

1.22

0.34

10.0

9.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.30

0.33

20.0

9.5

—

Necrosis of pulp, including avohilmo

109

1.28

0.32

9.9

10.1

—

Benign neoplasm: Colon, unspecified

1.28

0.32

3.3

8.8

—

Other hearing loss

1.28

0.32

8.8

8.5

—

Sleep disorders (combined)

133

0.83

0.31

8.6

9.3

—

Other menopausal disorders

1.31

0.31

11.6

6.5

—

Other intervertebral disc disorders

104

1.22

0.31

10.2

9.3

—

Lumbar disc prolapse

1.25

0.31

11.4

9.4

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.32

0.31

6.7

10.7

—

Constipation

120

1.21

0.31

10.0

9.3

—

Intracranial injury

1.28

0.30

12.5

9.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.28

0.30

12.0

9.2

—

Injuries to the thorax

1.31

0.29

8.1

9.7

—

Delivery

1.35

0.29

13.5

6.2

—

Dorsopathies

107

1.19

0.29

10.2

9.3

—

Fracture of rib(s), sternum and thoracic spine

1.25

0.29

9.1

9.5

—

Diseases of appendix

137

0.79

0.29

9.7

9.5

—

Injuries to the elbow and forearm

114

1.23

0.28

7.8

9.7

—

Alcohol use disorder, Swedish definition

1.27

0.28

8.2

10.4

—

Other retinal disorders

101

1.23

0.28

11.3

8.8

—

Transient ischemic attack

1.27

0.28

10.3

8.3

—

Symptoms and signs involving the circulatory and respiratory systems

1.19

0.27

9.4

10.0

—

Pulmonary heart disease, diseases of pulmonary circulation

1.25

0.27

5.5

9.3

—

Fracture of shoulder and upper arm

1.25

0.27

8.5

8.6

—

Pregnancy hypertension

0.70

0.26

4.8

9.0

—

Papulosquamous disorders

1.30

0.26

7.2

9.2

—

Rheumatoid arthritis, including avohilmo

0.68

0.26

4.0

8.3

—

Single spontaneous delivery

1.22

0.26

11.7

6.2

—

Appendicitis, broad definition

135

0.80

0.26

9.7

9.6

—

Temporomandibular joint disorders, including avohilmo

1.25

0.25

11.6

8.1

—

Varicose veins

0.79

0.25

10.6

7.8

—

Mental and behavioural disorders due to alcohol

1.25

0.25

6.3

10.7

—

Unspecific neurodegenerative disorder

0.72

0.24

8.5

8.0

—

Dementia

0.71

0.24

8.5

—

Dyspnoea

132

1.18

0.24

7.1

9.7

—

0.74

0.24

11.0

8.3

—

Disorders of breast

0.71

0.24

6.7

8.1

—

Other diseases of hard tissues of teeth

1.25

0.23

9.5

7.9

—

Insomnia

124

1.17

0.23

7.0

9.4

—

Cervicalgia

1.28

0.23

18.4

8.1

—

Fracture of foot, except ankle

1.28

0.23

12.2

9.2

—

Other viral diseases, not elsewhere classified

1.27

0.22

5.8

10.9

—

Peritonsillar abscess

1.25

0.22

13.4

9.9

—

Unspecified fall

0.75

0.22

12.3

10.0

—

Seborrhoeic keratosis

1.22

0.22

3.2

8.5

—

Inflammatory bowel disease, strict (require KELA)

1.22

0.22

10.2

10.3

—

Impingement syndrome of shoulder

1.22

0.22

5.0

8.7

—

Fibroblastic disorders

1.22

0.22

13.0

8.3

—

False labour

1.20

0.22

12.2

6.3

—

Other arthrosis

0.78

0.21

6.5

7.2

—

Organic, including symptomatic, mental disorders

0.79

0.21

7.3

8.3

—

Enthesopathies of lower limb, excluding foot

1.19

0.21

11.2

8.2

—

IBD patients in KELA-register

1.19

0.21

10.2

10.0

—

Normal-pressure hydrocephalus

0.00

0.21

0.0

9.5

—

L02BX Other hormone antagonists and related agents

0.00

0.21

0.0

8.3

—

Other secondary gonarthrosis

0.00

0.21

0.0

14.6

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

0.21

0.0

13.5

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.21

0.0

13.7

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

0.21

0.0

13.2

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

0.21

0.0

13.3

—

Varicose veins of other sites

0.00

0.21

0.0

11.3

—

Pedestrian injured in transport accident

0.00

0.21

0.0

12.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

12.9

—

Unknown and unspecified causes of morbidity

0.00

0.21

0.0

9.1

—

Cardiomyopathy, other and unspecified

0.00

0.21

0.0

7.4

—

Melanocytic naevi, other sites/unspecified

0.00

0.21

0.0

14.7

—

Allergic urticaria

0.00

0.21

0.0

12.6

—

Demyelinating diseases of the central nervous system

0.00

0.21

0.0

12.7

—

Scoliosis

0.00

0.21

0.0

13.2

—

Pilonidal cyst

0.00

0.21

0.0

10.8

—

Carcinoma in situ of cervix uteri

0.00

0.21

0.0

10.1

—

Eating disorders

0.00

0.21

0.0

12.2

—

Polycystic ovarian syndrome, broad definition

0.00

0.21

0.0

14.2

—

Vascular dementia

0.00

0.21

0.0

9.9

—

Disorders of calcium metabolism

0.00

0.21

0.0

13.6

—

Pleural plaque with presence of asbestos

0.00

0.21

0.0

8.9

—

Sicca syndrome [Sjögren]

0.00

0.21

0.0

12.4

—

Nail disorders

0.00

0.21

0.0

11.7

—

Sequelae of injuries of lower limb

0.00

0.21

0.0

13.3

—

Diseases of inner ear

0.78

0.21

5.8

8.4

—

Vasomotor rhinitis (mode)

0.00

0.21

0.0

13.5

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.21

0.0

15.8

—

Spirochaetal infections, other/unspecified

0.00

0.21

0.0

12.6

—

Disorders of mineral metabolism

0.00

0.21

0.0

12.6

—

Haemangioma, any site

0.00

0.21

0.0

14.9

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

7.5

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

14.9

—

Sequelae of injuries of upper limb

0.00

0.21

0.0

13.9

—

Infections of genitourinary tract in pregnancy

0.00

0.21

0.0

11.8

—

Neurological diseases

1.16

0.20

11.5

9.0

—

Disorders of choroid and retina

116

1.16

0.20

10.6

9.3

—

Use of antiglaucoma preparations and miotics

0.00

0.20

0.0

9.0

—

Other and unspecified glaucoma

0.00

0.20

0.0

9.0

—

Other superficial mycoses

0.00

0.20

0.0

13.6

—

Personal history of other diseases and conditions

0.00

0.20

0.0

12.9

—

Conjunctivitis

121

1.17

0.20

11.3

8.6

—

103

1.20

0.20

7.6

10.8

—

Primary coxarthrosis, bilateral

1.20

0.19

5.2

8.6

—

Deforming dorsopathies

1.20

0.19

10.3

8.8

—

Mycoses

143

1.16

0.19

12.5

8.8

—

Other diseases of urinary system

108

1.14

0.19

13.6

8.3

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.15

0.19

7.2

10.8

—

Open wound of wrist and hand

1.24

0.19

10.2

11.1

—

Delivery, wide proxy

1.16

0.18

12.1

5.3

—

Calculus of kidney and ureter

1.21

0.18

13.3

9.5

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.20

0.18

10.6

9.2

—

Endometriosis

1.14

0.17

9.4

7.0

—

Acute appendicitis

133

0.84

0.17

9.7

—

Abrasion of teeth

1.13

0.17

11.7

8.2

—

Care involving use of rehabilitation procedures

101

1.18

0.17

11.1

8.9

—

Excessive, frequent and irregular menstruation

1.18

0.17

11.6

6.8

—

Hernia of abdominal wall

1.22

0.17

5.5

9.2

—

Other disorders of lacrimal gland

0.76

0.17

16.6

8.9

—

Persons encountering health services in other circumstances

0.73

0.17

13.6

9.7

—

Other symptoms and signs involving cognitive functions and awareness

1.21

0.16

7.9

9.1

—

Skin changes due to chronic exposure to nonionizing radiation

0.76

0.15

11.0

8.4

—

Disorders of synovium and tendon

1.19

0.15

9.3

8.0

—

Missing teeth due to accident, extraction or parodontitis

105

1.17

0.15

8.2

8.6

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.80

0.14

9.0

8.6

—

Unspecified haematuria

1.20

0.14

8.3

9.8

—

Disorders of skin appendages

0.81

0.14

11.9

9.9

—

Hypothyroidism, other/unspecified

117

1.12

0.14

7.2

8.8

—

Inflammatory diseases of female pelvic organs

1.18

0.14

6.0

8.0

—

Tonsillectomy and adenotomy

0.80

0.14

16.8

9.0

—

Triptan medication for migraine, min. 3 purchases

0.79

0.13

9.1

9.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

127

1.12

0.13

8.3

9.3

—

Other maternal disorders predominantly related to pregnancy

0.84

0.13

13.1

7.8

—

Diseases of the skin and subcutaneous tissue

104

1.11

0.13

13.1

8.9

—

Acute appendicitis, no complications

106

0.84

0.13

10.2

9.8

—

Leiomyoma of uterus

1.15

0.12

11.7

6.8

—

Glaucoma

100

0.86

0.12

9.6

8.6

—

Fracture of forearm

1.14

0.11

9.6

9.1

—

Appendectomy

120

0.88

0.10

9.3

9.5

—

Degeneration of macula and posterior pole

1.15

0.10

9.0

8.5

—

Factors influencing health status and contact with health services

1.19

0.10

11.8

9.2

—

Diabetic retinopathy, excluding more controls

1.17

0.10

15.2

6.2

—

Other diseases of upper respiratory tract

115

1.09

0.10

10.5

9.1

—

Injuries to the wrist and hand

144

0.91

0.10

7.9

9.3

—

Benign neoplasm: Colon

101

1.13

0.10

11.5

8.6

—

Cellulitis

1.11

0.09

15.2

9.5

—

Ventral hernia

1.11

0.09

5.8

8.6

—

Type 1 diabetes

1.11

0.09

16.2

10.5

—

Disease of hard tissues of teeth, NOS

1.15

0.09

10.9

8.0

—

Congenital malformations, deformations and chromosomal abnormalities

101

1.13

0.09

9.4

9.5

—

Tinnitus

1.06

0.09

9.0

9.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.11

0.09

11.5

9.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

112

0.90

0.09

8.4

8.7

—

Hernia

123

1.09

0.09

9.2

9.6

—

Female genital prolapse

1.06

0.09

13.2

6.3

—

Sulfasalazine

1.09

0.08

5.0

9.7

—

Later onset COPD

1.06

0.08

6.8

9.5

—

Lyme disease

1.05

0.08

17.7

8.2

—

Other spirochaetal diseases

1.05

0.08

17.7

8.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.05

0.08

3.7

9.6

—

Pulmonary embolism

1.05

0.08

7.0

8.5

—

Dentofacial anomalies [including malocclusion]

109

1.10

0.08

11.6

9.2

—

Spirochaetal infections, other/unspecified

1.03

0.08

17.7

8.1

—

Other spirochaetal diseases

1.03

0.08

17.7

8.1

—

Pulmonary heart disease

1.03

0.08

7.0

8.3

—

Degenerative diseases of the nervous system

0.80

0.08

7.0

8.4

—

Hypothyroidism, strict autoimmune

0.90

0.08

8.0

9.1

—

Hallux valgus (acquired)

0.78

0.08

3.8

5.9

—

Pacemaker

0.83

0.08

14.6

8.6

—

Vasomotor and allergic rhinitis

0.79

0.08

11.6

9.5

—

Urticaria and erythema

0.79

0.08

9.4

9.2

—

Fitting and adjustment of other devices

1.11

0.08

10.9

8.0

—

Retinal detachments and breaks

1.08

0.08

4.9

8.9

—

Medicines for HER+ breast cancer

1.07

0.08

11.9

7.4

—

Sequelae of cerebrovascular disease

1.06

0.08

7.4

8.0

—

Noninflammatory disorders of female genital tract

0.81

0.08

13.8

6.8

—

Other benign neoplasms of skin

1.06

0.08

11.7

8.7

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.82

0.08

10.2

9.0

—

Diabetic retinopathy

0.83

0.08

17.2

8.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.12

0.08

10.7

10.0

—

Cervical disc disorders

1.03

0.07

10.0

8.6

—

Mouth breathing

0.86

0.07

4.5

10.1

—

Actinic keratosis

0.80

0.07

11.0

8.4

—

Hyperlipidaemia, other/unspecified

1.08

0.07

6.4

9.6

—

Disorders of lacrimal system

0.87

0.07

14.1

8.1

—

Presence of other functional implants

0.90

0.07

7.2

8.3

—

Diseases of the musculoskeletal system and connective tissue

1.13

0.07

12.7

8.1

—

Osteopathies and chondropathies

104

0.90

0.07

8.2

8.9

—

Disorders of vestibular function (Vertigo)

0.87

0.06

5.8

8.4

—

Meniscus derangement

0.87

0.06

11.7

7.4

—

Genitourinary diseases

1.10

0.06

12.7

8.9

—

Disorders of sclera, cornea, iris and ciliary body

102

0.88

0.06

8.9

9.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

123

1.07

0.05

7.2

9.0

—

Medical abortion

0.90

0.05

8.3

7.9

—

Gonarthrosis,primary

118

0.94

0.04

9.1

8.6

—

Disorders of the thyroid gland

123

1.06

0.04

9.1

9.0

—

Gonarthrosis [arthrosis of knee](FG)

1.07

0.04

11.8

8.3

—

Infections of the skin and subcutaneous tissue

108

0.92

0.04

14.0

9.4

—

Injuries to the ankle and foot

116

1.07

0.04

12.2

9.4

—

Migraine

1.10

0.03

11.3

8.3

—

Cholelithiasis

117

0.94

0.03

10.0

8.8

—

Dental pulpitis, including avohilmo

117

1.05

0.03

9.0

9.5

—

Dermatophytosis

112

1.07

0.02

12.9

9.1

—

Complications of labour and delivery

0.94

0.01

10.9

7.6

—

Cholelithiasis, broad definition with cholecystitis

119

0.96

0.01

10.2

8.9

—

Congenital malformations, deformations and chromosomal abnormalities

114

1.05

0.01

8.8

9.7

—

103

1.05

0.00

6.3

10.9

—

Caries of enamel

125

0.98

0.00

7.9

9.6

—

Episodal and paroxysmal disorders

125

1.02

0.00

11.7

9.0

—

Fracture of lower leg, including ankle

1.00

0.00

5.4

9.7

—

Pregnancy with abortive outcome

1.04

0.00

10.4

8.0

—

Inguinal hernia

0.95

0.00

10.2

10.5

—

Primary gonarthrosis, bilateral

1.05

0.00

4.8

8.7

—

Atopic dermatitis

1.00

0.00

6.5

10.0

—

Gonarthrosis

1.01

0.00

9.5

7.2

—

Injuries to the shoulder and upper arm

138

0.99

0.00

9.5

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.0

11.1

—

Other puerperal infections

0.00

0.0

7.3

—

MS-disease / Multiple Sclerosis

0.00

0.0

10.8

—

Respiratory tuberculosis, not confirmed

0.00

0.0

7.2

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

9.2

—

Diffuse brain injury

0.00

0.0

6.7

—

Additional codes for the location of defect, injury or illness

0.00

0.0

13.8

—

Sequelae of external causes of morbidity and mortality

1.00

0.00

10.2

8.8

—

Trigeminal neuralgia

0.00

0.0

8.9

—

Other and unspecified iridocyclitis

0.00

0.0

12.4

—

Lichen simplex chronicus and prurigo

0.00

0.0

14.0

—

0.00

0.0

6.7

—

Use of selegiline

0.00

0.0

10.8

—

Polycystic ovarian syndrome

0.00

0.0

11.4

—

Epilepsy

0.96

0.00

10.7

9.3

—

Nonspecific lymphadenitis

0.00

0.0

15.2

—

Asthma mixed form (mode)

0.00

0.0

6.4

—

Other viral hepatitis

0.00

0.0

12.7

—

Vascular dementia (subcortical)

0.00

0.0

8.2

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.0

13.5

—

Obesity due to excess calories

1.00

-0.00

5.9

9.8

—

Sulfonylureas

0.96

-0.00

6.3

9.2

—

Injury of muscle and tendon at shoulder and upper arm level

1.01

-0.00

7.1

9.1

—

Traumatic subarachnoid haemorrhage

0.00

-0.00

0.0

6.7

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

10.0

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

11.8

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

14.6

—

Symptoms and signs involving speech and voice

0.85

-0.00

9.6

7.6

—

therapeutic use

0.00

-0.00

0.0

11.5

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

-0.00

0.0

12.0

—

Asthma mixed form (mode), excluding more controls

0.00

-0.00

0.0

7.3

—

Contact with other sharp object(s)

0.00

-0.00

0.0

14.5

—

Other general symptoms and signs

0.00

-0.00

0.0

9.8

—

Other headache syndromes

1.00

-0.00

13.4

8.3

—

Convalescence

0.00

-0.00

0.0

15.7

—

ILD-related respiratory insufficiency

0.00

-0.00

0.0

14.2

—

0.91

-0.00

7.4

8.3

—

Obesity related asthma

0.94

-0.00

2.2

9.6

—

L02BG Aromatase inhibitors

1.00

-0.00

9.0

7.6

—

Other follicular disorders

0.00

-0.00

0.0

11.6

—

Use of ropinirole

0.00

-0.00

0.0

10.2

—

Use of biperiden

0.00

-0.00

0.0

12.4

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

14.6

—

Secondary parkinsonism, excluding more controls

0.00

-0.00

0.0

9.7

—

Presence of other devices

0.98

-0.00

10.6

7.7

—

Retention of urine

1.01

-0.00

11.0

9.8

—

Other disorders of eyelid

0.95

-0.00

8.1

8.3

—

Persons with potential health hazards related to communicable diseases

0.84

-0.00

10.8

9.7

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

10.0

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

14.2

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

10.4

—

Dementia in other diseases classified elsewhere

0.00

-0.00

0.0

9.2

—

Other cataract

0.93

-0.00

10.6

7.5

—

Melanoma in situ

0.00

-0.00

0.0

14.2

—

Viral infections of the central nervous system

0.00

-0.00

0.0

12.3

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

10.6

—

Bullous disorders

0.00

-0.00

0.0

12.1

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

13.1

—

Umbilical hernia

1.02

-0.00

5.2

9.2

—

All dysplastic lesions of the vulva

0.00

-0.00

0.0

15.6

—

Vitamin deficiency, wide

0.00

-0.00

0.0

11.5

—

Other osteochondropathies

0.00

-0.00

0.0

11.6

—

Gluteal tendinitis

0.00

-0.00

0.0

10.0

—

Medial epicondylitis

0.00

-0.00

0.0

10.0

—

Impacted maxillary molar

0.00

-0.00

0.0

10.0

—

Pyothorax

0.00

-0.00

0.0

14.2

—

Unspecified abortion

0.00

-0.00

0.0

9.4

—

Inflammatory disorders of breast

0.00

-0.00

0.0

14.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

12.2

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

-0.00

0.0

16.3

—

Other otitis externa (chronic)

0.00

-0.00

0.0

13.9

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

10.1

—

Pleural plaque without asbestos

0.00

-0.00

0.0

10.6

—

Ingrowing nail

0.00

-0.00

0.0

10.6

—

Corns and callosities

0.00

-0.00

0.0

13.9

—

Procreative management

0.83

-0.00

13.2

9.7

—

Other enthesopathies

0.89

-0.00

11.2

8.1

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

10.7

—

Vascular dementia (undefined)

0.00

-0.00

0.0

8.2

—

Raynaud syndrome

0.00

-0.00

0.0

14.9

—

Female infertility, associated with anovulation

0.00

-0.00

0.0

11.6

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

13.7

—

Oligomenorrhoea

0.00

-0.00

0.0

10.0

—

Noise effects on inner ear

0.00

-0.00

0.0

11.6

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

10.5

—

Heterophoria

0.00

-0.00

0.0

12.8

—

Maternal care for cervical incompetence

0.00

-0.00

0.0

8.4

—

Prepatellar bursitis

0.00

-0.00

0.0

9.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

13.7

—

Sub-endpoint used in defining T1D endpoints

0.88

-0.00

16.2

10.3

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

13.3

—

Cerebral cysts

0.00

-0.00

0.0

8.2

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

13.0

—

Vitamin deficiency

0.00

-0.00

0.0

11.5

—

Sacroiliitis, not elsewhere classified

0.00

-0.00

0.0

10.0

—

Other eating disorders

0.00

-0.00

0.0

10.6

—

Eating disorder

0.00

-0.00

0.0

13.6

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

10.3

—

Barrett oesophagus

0.00

-0.00

0.0

9.3

—

Dermatographic urticaria

0.00

-0.00

0.0

14.1

—

Other specified/unspecified systemic involvement of connective tissue

0.00

-0.00

0.0

15.1

—

Other deformities of toe(s)

0.00

-0.00

0.0

10.0

—

Visual impairment including blindness (binocular or monocular)

0.00

-0.00

0.0

13.3

—

Episcleritis

0.00

-0.00

0.0

13.0

—

Primary angle-closure glaucoma

0.00

-0.00

0.0

12.3

—

Other disorders of veins

0.95

-0.00

13.4

7.6

—

Dementia due to Parkinsons disease, excluding more controls

0.00

-0.00

0.0

9.0

—

Viral infections of the central nervous system

0.00

-0.00

0.0

12.3

—

Keratitis

0.88

-0.00

8.0

9.6

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

12.5

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

15.8

—

Presbyopia

0.00

-0.00

0.0

14.0

—

Extrapyramidal and movement disorders

0.97

-0.00

15.7

8.6

—

Infections with a predominantly sexual mode of transmission

0.86

-0.00

10.0

9.8

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

8.7

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

15.8

—

Sequelae of other external causes

0.00

-0.00

0.0

14.6

—

Carcinoma in situ of skin of scalp and neck

0.00

-0.00

0.0

10.0

—

Other aneurysm

0.00

-0.00

0.0

10.7

—

Disorders of orbit

0.00

-0.00

0.0

15.7

—

Rheumatoid arthritis

0.88

-0.00

4.0

6.4

—

Impotence

0.00

-0.00

0.0

10.4

—

Alcohol dependence

0.98

-0.00

3.2

10.9

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

15.8

—

Glaucoma secondary to other eye disorders

0.00

-0.00

0.0

10.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

-0.00

0.0

12.4

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

10.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS